A pan-serotype dengue virus inhibitor targeting the NS3–NS4B interaction

Dengue virus causes approximately 96 million symptomatic infections annually, manifesting as dengue fever or occasionally as severe dengue 1 , 2 . There are no antiviral agents available to prevent or treat dengue. Here, we describe a highly potent dengue virus inhibitor (JNJ-A07) that exerts nanomo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature (London) 2021-10, Vol.598 (7881), p.504-509
Hauptverfasser: Kaptein, Suzanne J. F., Goethals, Olivia, Kiemel, Dominik, Marchand, Arnaud, Kesteleyn, Bart, Bonfanti, Jean-François, Bardiot, Dorothée, Stoops, Bart, Jonckers, Tim H. M., Dallmeier, Kai, Geluykens, Peggy, Thys, Kim, Crabbe, Marjolein, Chatel-Chaix, Laurent, Münster, Max, Querat, Gilles, Touret, Franck, de Lamballerie, Xavier, Raboisson, Pierre, Simmen, Kenny, Chaltin, Patrick, Bartenschlager, Ralf, Van Loock, Marnix, Neyts, Johan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 509
container_issue 7881
container_start_page 504
container_title Nature (London)
container_volume 598
creator Kaptein, Suzanne J. F.
Goethals, Olivia
Kiemel, Dominik
Marchand, Arnaud
Kesteleyn, Bart
Bonfanti, Jean-François
Bardiot, Dorothée
Stoops, Bart
Jonckers, Tim H. M.
Dallmeier, Kai
Geluykens, Peggy
Thys, Kim
Crabbe, Marjolein
Chatel-Chaix, Laurent
Münster, Max
Querat, Gilles
Touret, Franck
de Lamballerie, Xavier
Raboisson, Pierre
Simmen, Kenny
Chaltin, Patrick
Bartenschlager, Ralf
Van Loock, Marnix
Neyts, Johan
description Dengue virus causes approximately 96 million symptomatic infections annually, manifesting as dengue fever or occasionally as severe dengue 1 , 2 . There are no antiviral agents available to prevent or treat dengue. Here, we describe a highly potent dengue virus inhibitor (JNJ-A07) that exerts nanomolar to picomolar activity against a panel of 21 clinical isolates that represent the natural genetic diversity of known genotypes and serotypes. The molecule has a high barrier to resistance and prevents the formation of the viral replication complex by blocking the interaction between two viral proteins (NS3 and NS4B), thus revealing a previously undescribed mechanism of antiviral action. JNJ-A07 has a favourable pharmacokinetic profile that results in outstanding efficacy against dengue virus infection in mouse infection models. Delaying start of treatment until peak viraemia results in a rapid and significant reduction in viral load. An analogue is currently in further development. The small molecule JNJ-A07 interferes with the interaction between the NS3 and NS4B proteins of dengue virus and reduces the viral load in mice even when first administered at peak viraemia.
doi_str_mv 10.1038/s41586-021-03990-6
format Article
fullrecord <record><control><sourceid>gale_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_04868312v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A679675666</galeid><sourcerecordid>A679675666</sourcerecordid><originalsourceid>FETCH-LOGICAL-c619t-c81a0e9b019312ef2f2c149f7263570259dcb89b82b0de9074365b087f8d06103</originalsourceid><addsrcrecordid>eNp9ks9u1DAQxiMEokvhBTigCE49uIxjx3-O24rSSqsisXC2nMTJutp1Utup6I136AvwLDwKT4KXlJaVVsgHSzO_-TTz6cuy1xiOMRDxPlBcCoagwAiIlIDYk2yGKWeIMsGfZjOAQiAQhB1kL0K4AoASc_o8OyCUYQaUzLLFPB-0Q8H4Pt4OJm-M60aT31g_hp8_rFvZysbe51H7zkTrujyuTH65JL--310u6cmWicbrOtrevcyetXodzKv7_zD7evbhy-k5Wnz6eHE6X6CaYRlRLbAGIyvAkuDCtEVb1JjKlheMlByKUjZ1JWQligoaI4FTwsoKBG9FAyydfpgdTborvVaDtxvtb1WvrTqfL9S2BlQwkbRvcGLfTezg--vRhKiu-tG7tJ4qSkF5WqGUj1Sn10ZZ1_Yx3bSxoVZzxiXjJWMsUWgP1RmXDFj3zrQ2lXf4t3v4erDX6l_oeA-UXmM2tt6rerQzkJhovsVOjyGoi-XnXbaY2Nr3IXjTPtiFQW1DpKYQqRQi9SdEajv05t6ysdqY5mHkb2oSQCYgpJbrjH_09D-yvwFc3M3z</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2584793159</pqid></control><display><type>article</type><title>A pan-serotype dengue virus inhibitor targeting the NS3–NS4B interaction</title><source>MEDLINE</source><source>SpringerLink Journals</source><source>Nature Journals Online</source><creator>Kaptein, Suzanne J. F. ; Goethals, Olivia ; Kiemel, Dominik ; Marchand, Arnaud ; Kesteleyn, Bart ; Bonfanti, Jean-François ; Bardiot, Dorothée ; Stoops, Bart ; Jonckers, Tim H. M. ; Dallmeier, Kai ; Geluykens, Peggy ; Thys, Kim ; Crabbe, Marjolein ; Chatel-Chaix, Laurent ; Münster, Max ; Querat, Gilles ; Touret, Franck ; de Lamballerie, Xavier ; Raboisson, Pierre ; Simmen, Kenny ; Chaltin, Patrick ; Bartenschlager, Ralf ; Van Loock, Marnix ; Neyts, Johan</creator><creatorcontrib>Kaptein, Suzanne J. F. ; Goethals, Olivia ; Kiemel, Dominik ; Marchand, Arnaud ; Kesteleyn, Bart ; Bonfanti, Jean-François ; Bardiot, Dorothée ; Stoops, Bart ; Jonckers, Tim H. M. ; Dallmeier, Kai ; Geluykens, Peggy ; Thys, Kim ; Crabbe, Marjolein ; Chatel-Chaix, Laurent ; Münster, Max ; Querat, Gilles ; Touret, Franck ; de Lamballerie, Xavier ; Raboisson, Pierre ; Simmen, Kenny ; Chaltin, Patrick ; Bartenschlager, Ralf ; Van Loock, Marnix ; Neyts, Johan</creatorcontrib><description>Dengue virus causes approximately 96 million symptomatic infections annually, manifesting as dengue fever or occasionally as severe dengue 1 , 2 . There are no antiviral agents available to prevent or treat dengue. Here, we describe a highly potent dengue virus inhibitor (JNJ-A07) that exerts nanomolar to picomolar activity against a panel of 21 clinical isolates that represent the natural genetic diversity of known genotypes and serotypes. The molecule has a high barrier to resistance and prevents the formation of the viral replication complex by blocking the interaction between two viral proteins (NS3 and NS4B), thus revealing a previously undescribed mechanism of antiviral action. JNJ-A07 has a favourable pharmacokinetic profile that results in outstanding efficacy against dengue virus infection in mouse infection models. Delaying start of treatment until peak viraemia results in a rapid and significant reduction in viral load. An analogue is currently in further development. The small molecule JNJ-A07 interferes with the interaction between the NS3 and NS4B proteins of dengue virus and reduces the viral load in mice even when first administered at peak viraemia.</description><identifier>ISSN: 0028-0836</identifier><identifier>EISSN: 1476-4687</identifier><identifier>DOI: 10.1038/s41586-021-03990-6</identifier><identifier>PMID: 34616043</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>13/1 ; 13/106 ; 38/109 ; 38/47 ; 38/70 ; 38/90 ; 631/154/555 ; 631/326/596/1413 ; 64/110 ; 82/80 ; Animal models ; Animals ; Antiviral activity ; Antiviral agents ; Antiviral Agents - pharmacokinetics ; Antiviral Agents - pharmacology ; Antiviral Agents - therapeutic use ; Clinical isolates ; Dengue ; Dengue - drug therapy ; Dengue - virology ; Dengue fever ; Dengue Virus - classification ; Dengue Virus - drug effects ; Dengue Virus - genetics ; Dengue Virus - metabolism ; Dengue viruses ; Development and progression ; Disease Models, Animal ; Drug resistance ; Drug therapy ; Female ; Fever ; Genetic diversity ; Genotypes ; Health aspects ; Humanities and Social Sciences ; Inhibitors ; Life Sciences ; Male ; Membrane Proteins - antagonists &amp; inhibitors ; Membrane Proteins - metabolism ; Mice ; multidisciplinary ; Mutation ; Pharmacokinetics ; Physiological aspects ; Protein-protein interactions ; RNA Helicases - antagonists &amp; inhibitors ; RNA Helicases - metabolism ; Science ; Science (multidisciplinary) ; Serine Endopeptidases - metabolism ; Serotypes ; Vector-borne diseases ; Viral diseases ; Viral Load - drug effects ; Viral Nonstructural Proteins - antagonists &amp; inhibitors ; Viral Nonstructural Proteins - metabolism ; Viral proteins ; Viremia ; Viremia - drug therapy ; Viremia - virology ; Virus Replication - drug effects ; Viruses</subject><ispartof>Nature (London), 2021-10, Vol.598 (7881), p.504-509</ispartof><rights>The Author(s), under exclusive licence to Springer Nature Limited 2021. corrected publication 2021</rights><rights>2021. The Author(s), under exclusive licence to Springer Nature Limited.</rights><rights>COPYRIGHT 2021 Nature Publishing Group</rights><rights>Copyright Nature Publishing Group Oct 21, 2021</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c619t-c81a0e9b019312ef2f2c149f7263570259dcb89b82b0de9074365b087f8d06103</citedby><cites>FETCH-LOGICAL-c619t-c81a0e9b019312ef2f2c149f7263570259dcb89b82b0de9074365b087f8d06103</cites><orcidid>0000-0002-8117-9166 ; 0000-0002-7390-8250 ; 0000-0001-5601-9307 ; 0000-0002-7935-0219 ; 0000-0002-0033-7514 ; 0000-0003-4151-4588 ; 0000-0002-2107-8857 ; 0000-0002-4734-2249</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/s41586-021-03990-6$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/s41586-021-03990-6$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,314,776,780,881,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34616043$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-04868312$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Kaptein, Suzanne J. F.</creatorcontrib><creatorcontrib>Goethals, Olivia</creatorcontrib><creatorcontrib>Kiemel, Dominik</creatorcontrib><creatorcontrib>Marchand, Arnaud</creatorcontrib><creatorcontrib>Kesteleyn, Bart</creatorcontrib><creatorcontrib>Bonfanti, Jean-François</creatorcontrib><creatorcontrib>Bardiot, Dorothée</creatorcontrib><creatorcontrib>Stoops, Bart</creatorcontrib><creatorcontrib>Jonckers, Tim H. M.</creatorcontrib><creatorcontrib>Dallmeier, Kai</creatorcontrib><creatorcontrib>Geluykens, Peggy</creatorcontrib><creatorcontrib>Thys, Kim</creatorcontrib><creatorcontrib>Crabbe, Marjolein</creatorcontrib><creatorcontrib>Chatel-Chaix, Laurent</creatorcontrib><creatorcontrib>Münster, Max</creatorcontrib><creatorcontrib>Querat, Gilles</creatorcontrib><creatorcontrib>Touret, Franck</creatorcontrib><creatorcontrib>de Lamballerie, Xavier</creatorcontrib><creatorcontrib>Raboisson, Pierre</creatorcontrib><creatorcontrib>Simmen, Kenny</creatorcontrib><creatorcontrib>Chaltin, Patrick</creatorcontrib><creatorcontrib>Bartenschlager, Ralf</creatorcontrib><creatorcontrib>Van Loock, Marnix</creatorcontrib><creatorcontrib>Neyts, Johan</creatorcontrib><title>A pan-serotype dengue virus inhibitor targeting the NS3–NS4B interaction</title><title>Nature (London)</title><addtitle>Nature</addtitle><addtitle>Nature</addtitle><description>Dengue virus causes approximately 96 million symptomatic infections annually, manifesting as dengue fever or occasionally as severe dengue 1 , 2 . There are no antiviral agents available to prevent or treat dengue. Here, we describe a highly potent dengue virus inhibitor (JNJ-A07) that exerts nanomolar to picomolar activity against a panel of 21 clinical isolates that represent the natural genetic diversity of known genotypes and serotypes. The molecule has a high barrier to resistance and prevents the formation of the viral replication complex by blocking the interaction between two viral proteins (NS3 and NS4B), thus revealing a previously undescribed mechanism of antiviral action. JNJ-A07 has a favourable pharmacokinetic profile that results in outstanding efficacy against dengue virus infection in mouse infection models. Delaying start of treatment until peak viraemia results in a rapid and significant reduction in viral load. An analogue is currently in further development. The small molecule JNJ-A07 interferes with the interaction between the NS3 and NS4B proteins of dengue virus and reduces the viral load in mice even when first administered at peak viraemia.</description><subject>13/1</subject><subject>13/106</subject><subject>38/109</subject><subject>38/47</subject><subject>38/70</subject><subject>38/90</subject><subject>631/154/555</subject><subject>631/326/596/1413</subject><subject>64/110</subject><subject>82/80</subject><subject>Animal models</subject><subject>Animals</subject><subject>Antiviral activity</subject><subject>Antiviral agents</subject><subject>Antiviral Agents - pharmacokinetics</subject><subject>Antiviral Agents - pharmacology</subject><subject>Antiviral Agents - therapeutic use</subject><subject>Clinical isolates</subject><subject>Dengue</subject><subject>Dengue - drug therapy</subject><subject>Dengue - virology</subject><subject>Dengue fever</subject><subject>Dengue Virus - classification</subject><subject>Dengue Virus - drug effects</subject><subject>Dengue Virus - genetics</subject><subject>Dengue Virus - metabolism</subject><subject>Dengue viruses</subject><subject>Development and progression</subject><subject>Disease Models, Animal</subject><subject>Drug resistance</subject><subject>Drug therapy</subject><subject>Female</subject><subject>Fever</subject><subject>Genetic diversity</subject><subject>Genotypes</subject><subject>Health aspects</subject><subject>Humanities and Social Sciences</subject><subject>Inhibitors</subject><subject>Life Sciences</subject><subject>Male</subject><subject>Membrane Proteins - antagonists &amp; inhibitors</subject><subject>Membrane Proteins - metabolism</subject><subject>Mice</subject><subject>multidisciplinary</subject><subject>Mutation</subject><subject>Pharmacokinetics</subject><subject>Physiological aspects</subject><subject>Protein-protein interactions</subject><subject>RNA Helicases - antagonists &amp; inhibitors</subject><subject>RNA Helicases - metabolism</subject><subject>Science</subject><subject>Science (multidisciplinary)</subject><subject>Serine Endopeptidases - metabolism</subject><subject>Serotypes</subject><subject>Vector-borne diseases</subject><subject>Viral diseases</subject><subject>Viral Load - drug effects</subject><subject>Viral Nonstructural Proteins - antagonists &amp; inhibitors</subject><subject>Viral Nonstructural Proteins - metabolism</subject><subject>Viral proteins</subject><subject>Viremia</subject><subject>Viremia - drug therapy</subject><subject>Viremia - virology</subject><subject>Virus Replication - drug effects</subject><subject>Viruses</subject><issn>0028-0836</issn><issn>1476-4687</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9ks9u1DAQxiMEokvhBTigCE49uIxjx3-O24rSSqsisXC2nMTJutp1Utup6I136AvwLDwKT4KXlJaVVsgHSzO_-TTz6cuy1xiOMRDxPlBcCoagwAiIlIDYk2yGKWeIMsGfZjOAQiAQhB1kL0K4AoASc_o8OyCUYQaUzLLFPB-0Q8H4Pt4OJm-M60aT31g_hp8_rFvZysbe51H7zkTrujyuTH65JL--310u6cmWicbrOtrevcyetXodzKv7_zD7evbhy-k5Wnz6eHE6X6CaYRlRLbAGIyvAkuDCtEVb1JjKlheMlByKUjZ1JWQligoaI4FTwsoKBG9FAyydfpgdTborvVaDtxvtb1WvrTqfL9S2BlQwkbRvcGLfTezg--vRhKiu-tG7tJ4qSkF5WqGUj1Sn10ZZ1_Yx3bSxoVZzxiXjJWMsUWgP1RmXDFj3zrQ2lXf4t3v4erDX6l_oeA-UXmM2tt6rerQzkJhovsVOjyGoi-XnXbaY2Nr3IXjTPtiFQW1DpKYQqRQi9SdEajv05t6ysdqY5mHkb2oSQCYgpJbrjH_09D-yvwFc3M3z</recordid><startdate>20211021</startdate><enddate>20211021</enddate><creator>Kaptein, Suzanne J. F.</creator><creator>Goethals, Olivia</creator><creator>Kiemel, Dominik</creator><creator>Marchand, Arnaud</creator><creator>Kesteleyn, Bart</creator><creator>Bonfanti, Jean-François</creator><creator>Bardiot, Dorothée</creator><creator>Stoops, Bart</creator><creator>Jonckers, Tim H. M.</creator><creator>Dallmeier, Kai</creator><creator>Geluykens, Peggy</creator><creator>Thys, Kim</creator><creator>Crabbe, Marjolein</creator><creator>Chatel-Chaix, Laurent</creator><creator>Münster, Max</creator><creator>Querat, Gilles</creator><creator>Touret, Franck</creator><creator>de Lamballerie, Xavier</creator><creator>Raboisson, Pierre</creator><creator>Simmen, Kenny</creator><creator>Chaltin, Patrick</creator><creator>Bartenschlager, Ralf</creator><creator>Van Loock, Marnix</creator><creator>Neyts, Johan</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7ST</scope><scope>7T5</scope><scope>7TG</scope><scope>7TK</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>BKSAR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PCBAR</scope><scope>PDBOC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>Q9U</scope><scope>R05</scope><scope>RC3</scope><scope>S0X</scope><scope>SOI</scope><scope>1XC</scope><scope>VOOES</scope><orcidid>https://orcid.org/0000-0002-8117-9166</orcidid><orcidid>https://orcid.org/0000-0002-7390-8250</orcidid><orcidid>https://orcid.org/0000-0001-5601-9307</orcidid><orcidid>https://orcid.org/0000-0002-7935-0219</orcidid><orcidid>https://orcid.org/0000-0002-0033-7514</orcidid><orcidid>https://orcid.org/0000-0003-4151-4588</orcidid><orcidid>https://orcid.org/0000-0002-2107-8857</orcidid><orcidid>https://orcid.org/0000-0002-4734-2249</orcidid></search><sort><creationdate>20211021</creationdate><title>A pan-serotype dengue virus inhibitor targeting the NS3–NS4B interaction</title><author>Kaptein, Suzanne J. F. ; Goethals, Olivia ; Kiemel, Dominik ; Marchand, Arnaud ; Kesteleyn, Bart ; Bonfanti, Jean-François ; Bardiot, Dorothée ; Stoops, Bart ; Jonckers, Tim H. M. ; Dallmeier, Kai ; Geluykens, Peggy ; Thys, Kim ; Crabbe, Marjolein ; Chatel-Chaix, Laurent ; Münster, Max ; Querat, Gilles ; Touret, Franck ; de Lamballerie, Xavier ; Raboisson, Pierre ; Simmen, Kenny ; Chaltin, Patrick ; Bartenschlager, Ralf ; Van Loock, Marnix ; Neyts, Johan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c619t-c81a0e9b019312ef2f2c149f7263570259dcb89b82b0de9074365b087f8d06103</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>13/1</topic><topic>13/106</topic><topic>38/109</topic><topic>38/47</topic><topic>38/70</topic><topic>38/90</topic><topic>631/154/555</topic><topic>631/326/596/1413</topic><topic>64/110</topic><topic>82/80</topic><topic>Animal models</topic><topic>Animals</topic><topic>Antiviral activity</topic><topic>Antiviral agents</topic><topic>Antiviral Agents - pharmacokinetics</topic><topic>Antiviral Agents - pharmacology</topic><topic>Antiviral Agents - therapeutic use</topic><topic>Clinical isolates</topic><topic>Dengue</topic><topic>Dengue - drug therapy</topic><topic>Dengue - virology</topic><topic>Dengue fever</topic><topic>Dengue Virus - classification</topic><topic>Dengue Virus - drug effects</topic><topic>Dengue Virus - genetics</topic><topic>Dengue Virus - metabolism</topic><topic>Dengue viruses</topic><topic>Development and progression</topic><topic>Disease Models, Animal</topic><topic>Drug resistance</topic><topic>Drug therapy</topic><topic>Female</topic><topic>Fever</topic><topic>Genetic diversity</topic><topic>Genotypes</topic><topic>Health aspects</topic><topic>Humanities and Social Sciences</topic><topic>Inhibitors</topic><topic>Life Sciences</topic><topic>Male</topic><topic>Membrane Proteins - antagonists &amp; inhibitors</topic><topic>Membrane Proteins - metabolism</topic><topic>Mice</topic><topic>multidisciplinary</topic><topic>Mutation</topic><topic>Pharmacokinetics</topic><topic>Physiological aspects</topic><topic>Protein-protein interactions</topic><topic>RNA Helicases - antagonists &amp; inhibitors</topic><topic>RNA Helicases - metabolism</topic><topic>Science</topic><topic>Science (multidisciplinary)</topic><topic>Serine Endopeptidases - metabolism</topic><topic>Serotypes</topic><topic>Vector-borne diseases</topic><topic>Viral diseases</topic><topic>Viral Load - drug effects</topic><topic>Viral Nonstructural Proteins - antagonists &amp; inhibitors</topic><topic>Viral Nonstructural Proteins - metabolism</topic><topic>Viral proteins</topic><topic>Viremia</topic><topic>Viremia - drug therapy</topic><topic>Viremia - virology</topic><topic>Virus Replication - drug effects</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kaptein, Suzanne J. F.</creatorcontrib><creatorcontrib>Goethals, Olivia</creatorcontrib><creatorcontrib>Kiemel, Dominik</creatorcontrib><creatorcontrib>Marchand, Arnaud</creatorcontrib><creatorcontrib>Kesteleyn, Bart</creatorcontrib><creatorcontrib>Bonfanti, Jean-François</creatorcontrib><creatorcontrib>Bardiot, Dorothée</creatorcontrib><creatorcontrib>Stoops, Bart</creatorcontrib><creatorcontrib>Jonckers, Tim H. M.</creatorcontrib><creatorcontrib>Dallmeier, Kai</creatorcontrib><creatorcontrib>Geluykens, Peggy</creatorcontrib><creatorcontrib>Thys, Kim</creatorcontrib><creatorcontrib>Crabbe, Marjolein</creatorcontrib><creatorcontrib>Chatel-Chaix, Laurent</creatorcontrib><creatorcontrib>Münster, Max</creatorcontrib><creatorcontrib>Querat, Gilles</creatorcontrib><creatorcontrib>Touret, Franck</creatorcontrib><creatorcontrib>de Lamballerie, Xavier</creatorcontrib><creatorcontrib>Raboisson, Pierre</creatorcontrib><creatorcontrib>Simmen, Kenny</creatorcontrib><creatorcontrib>Chaltin, Patrick</creatorcontrib><creatorcontrib>Bartenschlager, Ralf</creatorcontrib><creatorcontrib>Van Loock, Marnix</creatorcontrib><creatorcontrib>Neyts, Johan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Environment Abstracts</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Earth, Atmospheric &amp; Aquatic Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Earth, Atmospheric &amp; Aquatic Science Database</collection><collection>Materials Science Collection</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>ProQuest Central Basic</collection><collection>University of Michigan</collection><collection>Genetics Abstracts</collection><collection>SIRS Editorial</collection><collection>Environment Abstracts</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><jtitle>Nature (London)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kaptein, Suzanne J. F.</au><au>Goethals, Olivia</au><au>Kiemel, Dominik</au><au>Marchand, Arnaud</au><au>Kesteleyn, Bart</au><au>Bonfanti, Jean-François</au><au>Bardiot, Dorothée</au><au>Stoops, Bart</au><au>Jonckers, Tim H. M.</au><au>Dallmeier, Kai</au><au>Geluykens, Peggy</au><au>Thys, Kim</au><au>Crabbe, Marjolein</au><au>Chatel-Chaix, Laurent</au><au>Münster, Max</au><au>Querat, Gilles</au><au>Touret, Franck</au><au>de Lamballerie, Xavier</au><au>Raboisson, Pierre</au><au>Simmen, Kenny</au><au>Chaltin, Patrick</au><au>Bartenschlager, Ralf</au><au>Van Loock, Marnix</au><au>Neyts, Johan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A pan-serotype dengue virus inhibitor targeting the NS3–NS4B interaction</atitle><jtitle>Nature (London)</jtitle><stitle>Nature</stitle><addtitle>Nature</addtitle><date>2021-10-21</date><risdate>2021</risdate><volume>598</volume><issue>7881</issue><spage>504</spage><epage>509</epage><pages>504-509</pages><issn>0028-0836</issn><eissn>1476-4687</eissn><abstract>Dengue virus causes approximately 96 million symptomatic infections annually, manifesting as dengue fever or occasionally as severe dengue 1 , 2 . There are no antiviral agents available to prevent or treat dengue. Here, we describe a highly potent dengue virus inhibitor (JNJ-A07) that exerts nanomolar to picomolar activity against a panel of 21 clinical isolates that represent the natural genetic diversity of known genotypes and serotypes. The molecule has a high barrier to resistance and prevents the formation of the viral replication complex by blocking the interaction between two viral proteins (NS3 and NS4B), thus revealing a previously undescribed mechanism of antiviral action. JNJ-A07 has a favourable pharmacokinetic profile that results in outstanding efficacy against dengue virus infection in mouse infection models. Delaying start of treatment until peak viraemia results in a rapid and significant reduction in viral load. An analogue is currently in further development. The small molecule JNJ-A07 interferes with the interaction between the NS3 and NS4B proteins of dengue virus and reduces the viral load in mice even when first administered at peak viraemia.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>34616043</pmid><doi>10.1038/s41586-021-03990-6</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-8117-9166</orcidid><orcidid>https://orcid.org/0000-0002-7390-8250</orcidid><orcidid>https://orcid.org/0000-0001-5601-9307</orcidid><orcidid>https://orcid.org/0000-0002-7935-0219</orcidid><orcidid>https://orcid.org/0000-0002-0033-7514</orcidid><orcidid>https://orcid.org/0000-0003-4151-4588</orcidid><orcidid>https://orcid.org/0000-0002-2107-8857</orcidid><orcidid>https://orcid.org/0000-0002-4734-2249</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0028-0836
ispartof Nature (London), 2021-10, Vol.598 (7881), p.504-509
issn 0028-0836
1476-4687
language eng
recordid cdi_hal_primary_oai_HAL_hal_04868312v1
source MEDLINE; SpringerLink Journals; Nature Journals Online
subjects 13/1
13/106
38/109
38/47
38/70
38/90
631/154/555
631/326/596/1413
64/110
82/80
Animal models
Animals
Antiviral activity
Antiviral agents
Antiviral Agents - pharmacokinetics
Antiviral Agents - pharmacology
Antiviral Agents - therapeutic use
Clinical isolates
Dengue
Dengue - drug therapy
Dengue - virology
Dengue fever
Dengue Virus - classification
Dengue Virus - drug effects
Dengue Virus - genetics
Dengue Virus - metabolism
Dengue viruses
Development and progression
Disease Models, Animal
Drug resistance
Drug therapy
Female
Fever
Genetic diversity
Genotypes
Health aspects
Humanities and Social Sciences
Inhibitors
Life Sciences
Male
Membrane Proteins - antagonists & inhibitors
Membrane Proteins - metabolism
Mice
multidisciplinary
Mutation
Pharmacokinetics
Physiological aspects
Protein-protein interactions
RNA Helicases - antagonists & inhibitors
RNA Helicases - metabolism
Science
Science (multidisciplinary)
Serine Endopeptidases - metabolism
Serotypes
Vector-borne diseases
Viral diseases
Viral Load - drug effects
Viral Nonstructural Proteins - antagonists & inhibitors
Viral Nonstructural Proteins - metabolism
Viral proteins
Viremia
Viremia - drug therapy
Viremia - virology
Virus Replication - drug effects
Viruses
title A pan-serotype dengue virus inhibitor targeting the NS3–NS4B interaction
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T05%3A43%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20pan-serotype%20dengue%20virus%C2%A0inhibitor%20targeting%20the%20NS3%E2%80%93NS4B%C2%A0interaction&rft.jtitle=Nature%20(London)&rft.au=Kaptein,%20Suzanne%20J.%20F.&rft.date=2021-10-21&rft.volume=598&rft.issue=7881&rft.spage=504&rft.epage=509&rft.pages=504-509&rft.issn=0028-0836&rft.eissn=1476-4687&rft_id=info:doi/10.1038/s41586-021-03990-6&rft_dat=%3Cgale_hal_p%3EA679675666%3C/gale_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2584793159&rft_id=info:pmid/34616043&rft_galeid=A679675666&rfr_iscdi=true